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Dithiocarbamates are nitrogen- and sulfur-containing compounds commonly used in pharmacology,
medicine and agriculture. The molecular effects of dithiocarbamates on neuronal cell systems are not
fully understood, especially in terms of their ability to accumulate copper ions inside the cell. In this
work, the molecular effects of N,N-diethyldithiocarbamate (DEDTC) were studied in human SH-SY5Y neu-
roblastoma cells to determine the role of copper in the DEDTC toxicity and the pathway trigged in cell by
the complex Cu-DEDTC. From concentration-dependent studies, we found that 5 lM of this compound
induced a drastic decrease in viable cells with a concomitant accumulation in intracellular copper
resulted from complexation with DEDTC, measured by atomic absorption spectroscopy. The mechanism
of DEDTC-induced apoptosis in neuronal model cells is thought to occur through the death receptor sig-
naling triggered by DEDTC-copper complex in low concentration that is associated with the activation of
caspase 8. Our results indicated that the mechanism of cell death involves cytochrome c release forming
the apoptosome together with Apaf-1 and caspase 9, converting the caspase 9 into its active form, allow-
ing it to activate caspase 3 as observed by immunoﬂuorescence. This pathway is induced by the cytotoxic
effects that occur when DEDTC forms a complex with the copper ions present in the culture medium and
transports them into the cell, suggesting that the DEDTC by itself was not able to cause cell death and the
major effect is from its copper-complex in neuroblastoma cells. The present study suggests a role for the
inﬂuence of copper by low concentrations of DEDTC in the extracellular media, the absorption and accu-
mulation of copper in the cell and apoptotic events, induced by the cytotoxic effects that occur when
DEDTC forms a complex with the copper ions.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction DCs is currently being explored (Utrera et al., 2011). DCs have aDithiocarbamates (DCs) are sulfur-based metal chelators that
contain a dithiocarboxy functional group conjugated to an ali-
phatic secondary amino group. DCs are known to exert pro-oxidant
and antioxidant effects in both cell-free and biological systems
(Nobel et al., 1995). Their biological applications include wide-
spread use as agricultural insecticides, herbicides and fungicides
(Viquez et al., 2008). In addition to the use of disulﬁram in alcohol
aversion therapy (Eneanya et al., 1981) and N,N-diethyldithiocar-
bamate (DEDTC) in the treatment of nickel carbonyl intoxication
(Sunderman, 1979), a wide range of new medical applications for, dithiocarbamates; DEDTC,
ic absorption spectroscopy;
olium bromide; PI, propidi-
x: +55 11 4996 0090.
Cerchiaro).
sevier OA license.chemical structure wherein organic groups denote the nitrogen
substituent, which cause an inﬂuence on the binding site of sulfur
atom to the metal (Hulanick, 1967). Also, the chemical behavior of
DCs is determined by its substituents, which may be cyclic or ali-
phatic. Disubstituted DCs (tertiary) have the property of being ana-
lytically more stable, while monosubstituted (secondary) are less
stable because of its tendency to decomposition by the elimination
to form non-oxidized intermediates that play a signiﬁcant role in
their toxicity (Grosicka-Maciag et al., 2012; Safety et al., 1988).
Examples of tertiary DCs are pyrrolidine dithiocarbamate (PDTC)
and DEDTC, and some reports described that the toxicological
effects of these DCs occur by its Cu(II) complexation capacity.
(Tonkin et al., 2004; Lakomaa et al., 1982; Wu et al., 2012; Chen
et al., 2008a,b)
Many of the biological effects of DCs are based on their metal-
chelating properties. DEDTC derivative has been found to inhibit
copper/zinc superoxide dismutase activity by the withdrawal of
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ing cell death by apoptosis or necrosis. This toxicant has been
suggested to cause apoptosis or necrosis in HL60 cells by the
dose-dependent mediation of MAP kinase activation, suggesting
that maybe the copper levels inside the cell can inﬂuence the
mechanism of death (Kimoto-Kinoshita et al., 2004). The DEDTC-
copper complex [Cu(DEDTC)2] has been studied in cell metabolism
due to its action as a potential anticancer agent. It was found that
both DEDTC and DEDTC-copper complex administration in rats
were able to across the blood–brain barrier and after 24 h there
was an increase in brain copper concentrations which persisted
for atleast 3 days, independently of the extra-copper administra-
tion, and it has been suggested another role for copper uptake in
brain cells than direct copper chelation by DEDTC (Allain and Krari,
1993). Other studies focused on the cytotoxicity against carcinoma
cells suggested a role for [Cu(DEDTC)2] in the increase of Bax pro-
tein, DNA condensation and high catalase and glutathione peroxi-
dase levels using 0.3 lM of the copper-DEDTC complex added on
cell medium (Viola-Rhenals et al., 2006, 2007), and the copper-
DEDTC complex was suggested to be the toxicological agent. When
DEDTC was used without the presence of copper ions in the same
concentration (0.3 lM) in a cell medium complemented with fetal
bovine serum (a source of copper ions) no effects on carcinoma
cells were observed. Disulﬁram (DSF) also have been show to
facilitate the copper entrance in cells by the formation of copper-
DEDTC complex (Cen et al., 2004), the active form of DSF in the
presence of copper, which the induction of apoptosis in neuronal
cells remains unclear.
In order to contribute to the elucidation of DEDTC toxicology in
neuronal cells, we performed in vitro studies to elucidate the
molecular effects of DEDTC and its correlation with copper chela-
tion and concentration.2. Experimental procedures
2.1. Chemicals
Unless otherwise stated, the chemicals were obtained from Sig-
ma–Aldrich and were of analytical grade. The solutions were pre-
pared using Milli-Q water (Millipore, Bedford, MA, USA).
2.2. Cell culture
The cell media were prepared with DNase- and RNase-free
water and ﬁltered through 0.22-lm ﬁlter membranes (Millex GV,
Millipore) prior to use. The cell cultures were manipulated using
sterile, disposable non-pyrogenic plastic ware and were main-
tained at 37 C in an atmosphere of 5% CO2 in air at a relative
humidity of 80%. Human neuroblastoma SH-SY5Y cells were pur-
chased from the American Type Culture Collection (ATCC) and
grown in Dulbecco’s Modiﬁed Eagle F12 Medium (DMEM/F12)
supplemented with 10% heat-inactivated fetal bovine serum (Gib-
co), 100 U/ml penicillin and 10.0 lg/ml streptomycin. The cells
were routinely trypsinized and seeded at a density of 4  104 -
cells/cm2. Every month, the cells were cultivated in the absence
of antibiotics for control purposes and subjected to a routine assay
using a MycoAlert Mycoplasma Detection kit (Lonza Rockland) to
ensure that they had not become contaminated with mycoplasma.
All SH-SY5Y cells used in this study were used at a low passage
number (<15).
2.3. Cell viability assessment
To determine the levels of DEDTC that would promote maxi-
mum cell death, concentration-dependent cytotoxicity studieswere performed. Typically, viability of neuroblastoma cells was as-
sessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction assays, as previously reported (Mos-
mann, 1983). SH-SY5Y cells were inoculated in 96 well plates at
a density of 1  105 cell/well and incubated for 24 h under the con-
ditions described above. Aliquots of freshly prepared solutions of
DEDTC (5.0 mM) were added to the culture medium to attain ﬁnal
concentrations in the 1.0–100.0 lM range, and the plates were
then incubated for an additional 4, 12, 24, 48 and 96 h. The plates
were also incubated in the presence of sodium bathocuproine (BCS,
2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline) and in copper
free conditions. Based on these results (Fig. 1A), subsequent exper-
iments were conducted by incubating treated cells in medium sup-
plemented with DEDTC at a ﬁnal concentration of 5.0 lM with
control cells incubated in unsupplemented medium. Copper-free
conditions were achieved by incubating cells with DMEM contain-
ing either no serum or complement for 24 h prior to the addition of
DEDTC and for the subsequent assay incubation times.
Trypan Blue dye exclusion test was performed to conﬁrm the
MTT assay results. SH-SY5Y cells were inoculated in 25 cm2 cell
plate at a density of 4  104 cell/cm2 and incubated for 24 h under
the conditions described above. Aliquots of freshly prepared solu-
tions of DEDTC (5.0 mM) were added to the culture medium to at-
tain ﬁnal concentrations in the 5.0–100.0 lM range, and the plates
were then incubated for an additional 48 h. Following incubation,
the cells were trypsinized and combined, washed with phosphate
buffered saline (PBS; 137 mM NaCl and 2.7 mM KCl in 10 mM
phosphate buffer at pH 7.4), stained with Trypan blue and counted
under an optical microscope using a Neubauer chamber. Analysis
of cellular viability in MTT or Trypan Blue tests were done at least
in quintuplicate and represent independent replicates experiments
with cells in the passage between 5 and 15.
2.4. Solid sampling – graphite furnace atomic absorption spectroscopy
(GFAAS)
To determine intracellular copper concentrations, we employed
a ZEEnit 600 (Analytik Jena) model atomic absorption spectrome-
ter equipped with a transversely heated graphite atomizer, an in-
verse and transversal 2- and 3-ﬁeld mode Zeeman effect
background corrector, a manual sampling accessory and a hollow
copper cathode lamp. Pyrolytically coated heated graphite tubes
and pyrolytically coated boat-type solid sampling platforms (Anal-
ytik Jena) were used throughout the experiments. Argon
(99.998% v/v; Air Liquide Brasil) was used as a protective and purge
gas, and the instrumental parameters, experimental conditions and
heating program applied were similar to those previously de-
scribed (do Lago et al., 2011). All measurements were based on
the integrated absorbance values acquired with the aid of Win-
dows NT software.
2.5. Intracellular copper determination
SH-SY5Y cells were plated in a 25-cm2 culture ﬂask at a density
of 8  104 cells/cm2 and incubated in the presence or absence of
DEDTC (5.0 or 25 lM) for 6, 24 and 48 h. After incubation, the cells
were trypsinized and combined, washed twice with PBS containing
1.0 mM EDTA to remove residual Cu(II), washed three additional
times with PBS, and then dried for 1 wk in a desiccator. For the
GFAAS determination of copper, the dried cells were weighed di-
rectly onto the boat-type sampling platform with the aid of a Per-
kin-Elmer Auto Balance AD-4 (0.001 mg precision) and inserted
into the graphite furnace. The measurements were performed
three or ﬁve times using dried cell masses in the range of
20–250 lg. For calibration purposes, solutions containing
25–100 lg/l of Cu(II) were prepared by appropriate dilutions of a
Fig. 1. Viability of human SH-SY5Y neuroblastoma cells with DEDTC treatment. (A and B) MTT Assays. The cells were treated with 0–100.0 lMDEDTC in 4, 12, 24, 48 and 96 h
(A), and with 5.0 lM DEDTC in the presence of BCS or free copper medium in 4, 12, 24, 48 and 96 h (B). (C) Trypan Blue exclusion dye assay, cells were treated with 0–
100.0 lM DEDTC in 48 h, stained and counted. The data represent mean values ± standard deviation (n = 5). Signiﬁcant differences between the DEDTC-treated and untreated
cells are indicated by asterisks: ⁄p < 0.05 and ⁄⁄p < 0.001.
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Experiments of atomic absorption were done at least in quintupli-
cate and represent independent replicates experiments with cells
in the passage between 5 and 15.
2.6. Intracellular zinc determination
SH-SY5Y cells were plated in a 25-cm2 culture ﬂask at a density
of 8  104 cells/cm2 and incubated in the presence or absence of
DEDTC (5.0 lM) for 6, 24 and 48 h. After incubation, the cells were
trypsinized and combined, washed twice with PBS containing
1.0 mM EDTA to remove residual Zn(II), washed three additional
times with PBS, and then dried for 1 wk in a desiccator. The Zn
detection was performed with a ﬂame atomic absorption spec-
trometer Model AAS Vario 6 (Analytik Jena AG,Jena, Germany)
equipped with a hollow zinc cathode lamp and a deuterium lamp
for background correction. A sliding-bar injector-commutator de-
signed for ﬂow injection analysis was employed to insert the solu-
tions in the F AAS nebulizer. The instrumental parameters were:
wavelength 231.9 nm, spectral resolution 0.8 nm, current 3 mA,
burner height 9 mm, acetylene ﬂow rate 70 l/h, air ﬂow rate
400 l/h. A calibration curve was made with successive dilutions
of 1000 mg/l Zn stock solution. A concentration between 0.25
and 2.0 mg/l was used in F AAS analysis. All samples were submit-
ted to acid decomposition by adding HNO3 15% v/v into sample
ﬂasks, resulting in a total volume of 150 ll. All solutions were then
submitted to heating at 100 C in a hot water bath for 30 min. The
absorbance values obtained for total Zn determination wasobtained in triplicate by the injection of 100 ll of the digested
samples to F AAS system using an injector-commutator. Analytical
reference solutions of Zn were prepared by successive dilutions of
a stock solution containing 1.00 g/l (Merck). For sample decompo-
sitions, HNO3 (Merck) was used.
2.7. Apoptosis assay
The percentage of cells undergoing apoptosis was determined
by Annexin V staining using the ApopNexinTM FITC Apoptosis
Detection Kit (Millipore) in a ﬂow cytometer. SH-SY5Y cells were
seeded in 6-well plates and treated for 12, 24 and 48 h with
5.0 lM DEDTC. The cells were harvested and washed in ice-cold
PBS buffer. The cell pellet was resuspended in 200 ll of binding
buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2)
and incubated with FITC-labeled Annexin V and PI for 15 min. PI
was added to distinguish necrotic cells (Annexin V/PI+) from
early apoptotic cells (Annexin V+/PI) and late apoptotic cells (An-
nexin V+/PI+). A ﬂow cytometric analysis (Cytometer FC 500 MPL –
Beckman Coulter) was performed to determine the percentage of
apoptotic cells in each sample. Apoptosis assays were done at least
7 times in independent replicates experiments.
2.8. Cell cycle
The cell cycle proﬁles were determined by analyzing the per-
centages of cells with G1, S and G2 DNA content. SH-SY5Y cells
were plated in 6-well plates and treated for 24 and 48 h with
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twice with PBS and resuspended in 500 ll of a PBS solution con-
taining 5 lg/ml PI, 0.1% Triton X-100 and 0.2 mg/ml RNase. The
cells were incubated in this solution for 1 h and then analyzed by
ﬂow cytometry. Cell cycle proﬁles were done at least in quintupli-
cate and represent independent replicates experiments.
2.9. Western blot analysis
SH-SY5Y cells were plated and incubated in the presence or ab-
sence of DEDTC (5.0 lM) as described above. At 12 and 24 h after
treatment, the cells were harvested, resuspended and lysed in
150 ll of RIPA buffer (150 mM NaCl, 5 mM EDTA, 1 mM dithiothre-
itol, 1% Triton X-100, 0.5% sodium deoxycholate and 0.1% SDS in
50 mM Tris at pH 7.5) containing a protease inhibitor cocktail for
mammalian cells (Sigma–Aldrich) and centrifuged (14000g,
20 min, 4 C). The supernatants and pellets were transferred to
new Eppendorf tubes and stored at 80 C until required for anal-
ysis. The protein concentrations were determined according to the
method of (Lowry et al. (1951)) using bovine serum albumin (BSA)
as the standard. Then, 100 lg extracts were subjected to SDS–PAGE
and blotted onto nitrocellulose membranes (GE Healthcare Life Sci-
ences) with the equal loading of the proteins conﬁrmed by the
internal mass control blotting of b-actin. The membranes were
blocked for 1 h in a blocking solution containing 5% nonfat dried
milk (Sigma–Aldrich) and 0.0025% sodium azide solubilized in
TBS-T (150 mM NaCl, 50 mM Tris at pH 7.5 and 0.05% Tween-20)
and then washed twice with TBS-T. The primary antibodies em-
ployed were the mouse anti-p53 (2B2.71 sc-71819; Santa Cruz Bio-
technology), rabbit anti-caspase 8 (SK-16; Sigma–Aldrich), rabbit
anti-caspase 3 (Sigma–Aldrich) and mouse anti-b-actin (clone
AC-74; Sigma–Aldrich) monoclonal antibodies. The protein com-
plexes that were formed following treatment with the speciﬁc sec-
ondary antibodies (anti-mouse or anti-rabbit IgG-peroxidase
conjugate) were detected using the SuperSignal West Pico chemi-
luminescent substrate (Thermo Fisher Scientiﬁc). Westerns blot-
tings were done at least in triplicate and represent independent
replicate experiments.
2.10. Immunocytochemistry
SH-SY5Y cells were grown on chamber slides at a density of
0.5  104 cells/cm2 and then treated with 5 lM DEDTC. After 24-
h treatment, the cells were pre-ﬁxed with 2% paraformaldehyde di-
luted in cells medium (v/v) followed by a 1% parafolmaldehyde
post-ﬁxation. Brieﬂy the slides were washed twice with ice-cold
PBS for 3 min, and then permeabilized with PBS containing 0.2%
Triton X-100 for 30 min. The permeabilized cells were treated with
a blocking solution (PBS containing 2% non-immune goat serum
(NGS), 4% bovine serum albumin (BSA), 0.2% Triton X-100) and
then incubated with PBS containing 1% BSA, mouse anti-caspase
9 (clone CAS9; Sigma–Aldrich, 1:20) monoclonal antibody, and
sheep anti-cytochrome c (Chemicon International, 1:20) polyclonal
antibody at 4 C overnight. After washing with PBS, the cells were
incubated in PBS containing Alexa Fluor 488 donkey anti-sheep IgG
(Invitrogen, 1:100), Alexa Fluor 546 goat anti-mouse IgG (Invitro-
gen, 1:100) and 300 nM DAPI solution (Invitrogen) at 37 C for
3 h. The cells were then washed with PBS. The coverslips were
mounted in a glycerol/PBS solution (1:1 v/v), and the cells were
examined using a confocal laser-scanning microscope (ZEISS
LSM510 Meta/UV). All images were analyzed by Zeiss LSM Image
Browser Version 4.2.0.121 software). Negative controls were in-
cluded by replacing the speciﬁc primary antibody with normal ser-
um 3% BSA in glass slides treated or not with 5 lM DEDTC and
followed by appropriate secondary antibodies as described above
(Supporting information). Immunocytochemical images were doneat least in triplicate independent experiments. Fig. 4 shows a rep-
resentative image from the triplicate experiment, where each ﬁg-
ure representing more than ﬁve similar images in the same slide.2.11. Statistical analyses
All experiments were repeated at least ﬁve times in indepen-
dent replicates (except where stated otherwise), and the results
are expressed as the mean values ± standard deviations. The anal-
ysis of variance (ANOVA) with Bonferroni’s correction was used to
evaluate the differences between the means, with the level of sig-
niﬁcance set at p < 0.05.3. Results
The effects of N,N-diethyldithiocarbamate (DEDTC) on the via-
bility of SH-SY5Y neuroblastoma cells were initially assessed by
MTT and Trypan Blue viability test. Based on the results obtained
from these dose-dependent test (Fig. 1), where cells presented low-
er viability in low concentrations of DEDTC during the time than in
higher concentrations of this treatment, and the concentration of
5.0 lM was selected for further experiments due to the death pro-
ﬁle that was detected in cells at this concentration. All DEDTC con-
centrations caused a decrease in cell viability during the ﬁrst 24 h
of treatment when compared with the control (Fig. 1A). However,
after 48 h of incubation, the cells treated with 5.0 lM DEDTC had a
pronounced decrease in their viability, in contrast to the cells trea-
ted with higher concentrations that exhibited an increase in viable
cells after 48 h of incubation (Fig. 1A). The effects of free copper
medium or BCS added to the medium to chelate copper ions in con-
trol experiments showed none or marginal effects on cell viability
in the presence of DEDTC (Fig. 1B). Intracellular levels of copper in
the SH-SY5Y cells were analyzed using graphite furnace atomic
absorption spectroscopy (GFAAS). The cells were treated with DED-
TC for 6, 24 and 48 h, and then subjected to atomic absorption
spectroscopy. The results showed that the DEDTC-treated cells
exhibited an increased amount of intracellular copper within the
ﬁrst 6 h of incubation compared with the untreated cells and had
an accumulation proﬁle of copper during that time (Fig. 2A). Com-
paratively, copper uptake in cells were lower using DEDTC 25 lM
(Fig. 2A).
These results suggested that the chelating agent DEDTC at low
concentration induced the intracellular accumulation of copper
in SH-SY5Y neuroblastoma cells, which could inﬂuence the de-
crease in cell viability observed during the ﬁrst 24 h of treatment.
Studies were performed with copper-free culture medium (Fig. 2B)
to prevent the complexation and transport of exogenous copper by
the cell, but these experiments revealed no changes in the copper
uptake or removal in the cells during the period of the study. The
intracellular zinc content was examined by atomic absorption
spectroscopy but revealed no zinc uptake by cells subjected to sim-
ilar DEDTC treatments (Figure S1). To determine the inﬂuence of
DEDTC in the cell cycle the nuclei were stained with propidium io-
dide (PI) prior to ﬂow cytometry analysis. The cell cycle studies re-
vealed that cells treated with DEDTC exhibited no changes in the
cell cycle during the ﬁrst 24 h of treatment (Fig. 2C) compared with
the control cells. However, within 48 h of incubation, the treat-
ment induced an increase in the population of cells in the sub-
G1 phase and a slight decrease in the G2/M phase. Approximately
0.7% of the control cells were in the sub-G1 phase, while approxi-
mately 10% of the cells treated with 5 lM DEDTC were in this
phase (Fig. 2C). To verify if this increase in the sub-G1 population
was due to apoptosis, SH-SY5Y cells were labeled with FITC-conju-
gated Annexin V and PI for ﬂow cytometry analysis. The results of
the ﬂow cytometry study with Annexin V/FITC and PI showed that,
Fig. 2. DEDTC causes copper uptake from medium and cell cycle alterations. (A) The uptake of copper was determined by solid sampling-graphite furnace atomic absorption
spectroscopy. The concentrations of copper in cells treated with 5.0 and 25 lMDEDTC and in untreated cells for periods of 6, 24 and 48 h are shown. The curve ﬁt was done by
Hill equation [y = Vmax (xn/(kn + xn)] in a Origin 8.0 Data Analysis Program, by OriginLab; (B) The uptake of copper was determined as described above with a medium without
fetal bovine serum; (C) Cell cycle distribution of SH-SY5Y cells after treatment with 5.0 lM DEDTC for 24 and 48 h. The cells were treated with RNase and propidium iodide
and then analyzed by ﬂow cytometry. The cell cycle distributions were calculated with the WinMDI 2.8 software. The results are displayed as the histograms of cell numbers
(counts) versus DNA content (propidium iodide) and are representative of ﬁve independent experiments. The data represent mean values ± standard deviations (n = 5).
Signiﬁcant differences between the DEDTC-treated and untreated cells are indicated by asterisks, ⁄⁄p < 0.001.
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Fig. 3. Apoptosis analysis: effect of DEDTC on downstream signaling, leading to apoptosis. (A) SH-SY5Y cells were treated with 5.0 lM DEDTC. At each time point, 100 lg of
proteins from the total cell lysates was loaded onto each lane for the detection of caspase 8, caspase 3 and p53. b-actin was used as a loading control, and the densitometry of
each lane (represented as bars) was calculated using the Quantity One software. The data are expressed as arbitrary units of each protein and represent the mean ± SD of n = 3
independent experiments, ⁄p < 0.01; ⁄⁄p < 0.001. (B) Dot plot of SH-SY5Y after exposure to 5.0 lMDEDTC for 12, 24 and 48 h and ﬂow cytometry analysis with Annexin V-FITC
versus PI. The divisions of the plots distinguish necrotic cells (Annexin V/PI+, left upper quadrant) from early apoptotic cells (Annexin V+/PI, right lower quadrant) and late
apoptotic cells (Annexin V+/PI+, right upper quadrant). The plots in the ﬁgure are representative of seven independent experiments.
354 A.C. Matias et al. / Toxicology in Vitro 27 (2013) 349–357within 12 h of incubation, approximately 7% of the cells treated
with 5 lM DEDTC underwent early apoptosis compared to the less
than 2% of apoptotic cells observed in the control. During thecourse of the incubation period 12% of the cells were in early apop-
tosis and 5% in late apoptosis following 48 h of incubation (Fig. 3B,
treatment). The untreated cells maintained a similar percentage of
Fig. 4. Effect of DEDTC on the neuroblastoma cytoplasmic network. (A) SH-SY5Y cells were grown on chamber slides and treated for 24 h with 5.0 lM DEDTC. After ﬁxation,
the cells were probed with cytochrome c- and caspase-9-speciﬁc antibodies, the respective secondary antibodies and DAPI staining. The images of the cells were digitized
with an LMS Image Browser from images obtained in a confocal laser-scanning microscope (Zeiss LSM510 Meta/UV). The expressed images represent n = 3 similar
independent experiments. The images were analyzed by Zeiss LSM Image Browser Version 4.2.0.121 software.
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cells remaining viable (Fig. 3B, control). Due to the percentage of
cells entering apoptosis upon treatment with 5 lM DEDTC, the
apoptotic pathways were investigated to determine a molecular
mechanism for this event.
The results of the Western blot analysis of cells treated with
5 lM DEDTC showed an approximately 15% increase in caspase 8
protein levels compared with the untreated cells. The same proﬁle
was observed after 24 h of incubation with a 28% increase in cas-
pase-8 levels (Fig. 3A). Caspase 3 was also observed to increase
upon DEDTC treatment, particularly when the cells were treated
for 24 h, as this effector caspase is activated after caspase 8. The
levels of p53 were also increased at all incubation times compared
with their respective controls, with a greater increase in the ﬁrst
12 h of treatment with 5 lM DEDTC that remained constant until
24 h following the addition of DEDTC (Fig. 3A). Levels of Bcl-2 pro-
tein in cells treated with DEDTC remained unchanged and similar
to control cells for 24 h (data not shown). To better understand
the way in which the apoptotic cascade was activated, we em-
ployed immunocytochemistry with colocalization. The results
showed that the untreated cells (Fig. 4A) exhibited no signiﬁcant
morphological changes. Sparse markings for cytochrome c and alow ﬂuorescence intensity for caspase 9 were observed, and
although these proteins were localized near one another, they
did not overlap (Fig. 4C). The visualization of the cells treated with
5 lM DEDTC (Fig. 4B) showed numerous cells in the process of the
retraction of the cytoplasm in numerous blebs and vacuoles, nucle-
ar pyknosis (with a distinct staining for cytochrome c), and a high
level of caspase 9 (shown in orange). Caspase 9 and cytochrome c
were observed to colocalize, indicating the presence of a dense for-
mation of complexes containing numerous intimately combined
caspase 9 and cytochrome c units (dotted region in red and white
dashes in Fig. 4D), which suggests the formation of the
apoptosome.4. Discussion
Over the last decade, several DCs have been explored to study
the absorption of metal ions, and their ability to cause apoptosis
in a variety of cells has been observed (Cen et al., 2004; Valentine
et al., 2009; Tonkin et al., 2004). Studies indicate that the pharma-
cological and toxicological effects of DCs are derived from their for-
mation of copper ion complexes (Ding et al., 2011; Daniel et al.,
356 A.C. Matias et al. / Toxicology in Vitro 27 (2013) 349–3572005), while some others suggest another role for copper uptake in
brain cells than direct copper chelation by DEDTC (Allain and Krari,
1993). Although studied in inducing apoptosis in carcinoma and
melanoma cells (Cen et al., 2004; Viola-Rhenals et al., 2006,
2007), the effects of DEDTC in brain cells remain under scrutiny.
In our studies, we found that DEDTC induced cell death in human
SH-SY5Y neuroblastoma cells and that this induction was related
to the concentration of DEDTC and the time of incubation in the
culture medium, and the concentration of 5 lM showed to de-
crease signiﬁcantly the cell viability and increased the intracellular
level of copper in cells. The supplementation of the culture med-
ium with fetal bovine serum was the common external source of
copper in our experiments, as demonstrated by the control exper-
iments. Zinc was found to have no inﬂuence on the effects of
DEDTC. Neuroblastoma cells were cultivated in copper-free med-
ium with no addition of fetal bovine serum for the 48 h treatment
to ensure that both DEDTC-treated and untreated cells had the
same level of intracellular copper. This ﬁnding suggests that, when
DEDTC was present in the copper-containing medium, it could
chelate extracellular copper and transport it into the cell but could
not remove copper from the cells or form complex with the low
intracellular copper content, being in equilibrium with external
medium. It is known that the polarity of the nitrogen substituent
inﬂuences the lipophilic aspect of DC copper complexes and the
ability of the Cu(DEDTC)2 complex to promote the accumulation
of copper in the target tissue or organelle that induces toxic effects
(Valentine et al., 2009; Warshawsky et al., 2001). In 1995, (Nobel
et al. (1995)) demonstrated that another DC, pyrrolidine dithiocar-
bamate (PDTC), induces apoptosis in thymocytes by increasing the
intracellular level of copper and, consequently, changing the redox
activity in the medium, a similar result obtained here, but with
relation with time and concentration of the DC. (Viquez et al.
(2008)) suggested that DEDTC had the ability to accumulate
copper, leading to lipid oxidation and damage with myelin inﬂam-
mation in rats. Our studies showed that the cellular response was
inﬂuenced by the DEDTC concentration with a non-linear
accumulation of copper inside the cell. The effect of a higher DED-
TC concentration that did not cause cell toxicity – as 25 lM – is a
lower intracellular copper accumulation than DEDTC at 5 lM,
proving that copper content inside the cell can be responsible for
the effects of DEDTC toxicity. Consequently, the intracellular accu-
mulation of copper could generate oxidative stress with the forma-
tion of reactive oxygen species (ROS); many studies have reported
the inﬂuence of copper on the formation of ROS in neuroblastoma
cells that causes DNA damage (Arciello et al., 2005; Marengo et al.,
2005; Gabbianelli et al., 1999; Filomeni et al., 2007). Our results of
the cell cycle studies (Fig. 2C) showed an increase in number of
cells in the sub-G1 phase upon DEDTC treatment, conﬁrming that
the chelation caused some damage to cellular DNA. This result
was conﬁrmed by Annexin V/FITC and PI ﬂow cytometry studies
that showed an increase in the sub-G1 population during the incu-
bation with DEDTC, clearly indicating an apoptotic process
(Fig. 3B). The tumor suppressor protein p53 is a transcription factor
that regulates cell cycle progression and DNA repair in cells ex-
posed to genotoxic stress (Culmsee and Mattson, 2005). In many
types of cells, the accumulation of p53 triggers apoptosis (Morrison
et al., 2003; Meulmeester and Jochemsen, 2008). Our results sug-
gested that DEDTC induced the accumulation of p53 (Fig. 4) and,
thus, triggered apoptosis in the SH-SY5Y cells. Apoptosis is regu-
lated and executed by two main families of proteins, the Bcl-2 fam-
ily and caspases (Aravind et al., 1999; Hacker et al., 2011), and their
activation can be initiated in two different ways, the extrinsic
pathway (cytoplasmic) or the intrinsic pathway (mitochondrial).
Our intention was to clarify the role of caspase 8 in p53-dependent
apoptosis induced by DEDTC. Caspase 8 is a key upstreammediator
in death receptor-mediated apoptosis and also participates inmitochondria-mediated apoptosis via the cleavage of proapoptotic
Bid. In our studies, the observed activation of caspases 8 and 3
(Fig. 3A) and the unchanged levels of Bcl-2 (data not shown) sug-
gested that the mechanism of DEDTC-induced apoptosis mainly in-
volved the extrinsic pathway. This pathway is known to be
initiated by the interactions of speciﬁc ligands with a group of
membrane receptors from the tumor necrosis factor (rTNF) recep-
tor superfamily, which can (Budihardjo et al., 1999). In this case,
the copper complex with DEDTC in low concentration can trigger
this pathway.We also observed an increased release of cytochrome
c by confocal microscopy during the activation of caspase 9 in cells
treated with DEDTC (Fig. 4B) when compared with the control un-
treated cells (Fig. 4A). In the merged image (Fig. 4D), we observed
the presence of a ﬁgure that suggested a dense formation of com-
plexes containing numerous intimately combined caspase 9 and
cytochrome c molecules, implicating the formation of the
apoptosome.
In this study, the mechanism of DEDTC-induced apoptosis in
neuronal model cells is thought to occur through the death recep-
tor signaling triggered by DEDTC-copper complex in low concen-
tration that is associated with the activation of caspase 8. This
caspase is involved with the mitochondrial tBid apoptotic signaling
pathway, leading to the release of apoptogenic factors, such as
cytochrome c, into the cytosol. Cytochrome c, together with
Apaf-1 and caspase 9, forms the apoptosome and converts caspase
9 into its active form, allowing it to activate caspase 3 as we ob-
served, which then executes programmed cell death. Thus, our re-
sults indicate that this mechanism is likely responsible for DEDTC-
induced apoptosis in human SH-SY5Y neuroblastoma cells. This
pathway is induced by the cytotoxic effects that occur when DED-
TC forms a complex with the copper ions present in the culture
medium and transports them into the cell, suggesting that the
DEDTC by itself was not able to cause cell death and the major ef-
fect is from its copper-complex in neuroblastoma cells.Acknowledgments
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